Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/19/25 17:44 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Decheng Capital Global Life Sciences Fund Iv, L.P. | E9 | T | P.d | 20,000 | 16.00 | 0 | 1,250 | 47 | 3,917 | I | |||||||||||||||
2/19/25 16:35 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | P.d | 265 | 16.00 | 0 | 17 | 1 | 2,970 | D | ||||||||||||||
2/19/25 16:30 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Sun Nelson | CA | O | CFO | P.d | 160 | 16.00 | 0 | 10 | 11 | 99 | D | ||||||||||||||
2/19/25 16:02 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 3,000 | 16.00 | 0 | 188 | 23 | 988 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |